Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Sarepta Therapeutics, Inc. (SRPT)

Johnson Fistel, PLLP is soliciting Sarepta Therapeutics shareholders to participate in an investigation concerning alleged breaches of fiduciary duty by certain officers and directors. The investigation relates to a previously filed class action complaint alleging that the company made misleading statements regarding the safety profile and commercial prospects of its gene therapy, ELEVIDYS.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.